Cocrystal Pharma, Inc. — Form 8-K
Filed July 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Cocrystal Pharma filed an 8-K on 2026-07-17 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) with a period of report date of 2026-07-14. The filing contains only technical SEC documentation and XBRL data files. No specific voting matter details, proposal descriptions, vote results, share counts, or dollar amounts are provided in the accessible filing text.
Why this rating
Routine procedural filing with no substantive disclosure of voting details or business impact. No quantitative metrics or material developments disclosed relative to ~$11.6M market cap.
Extracted items
See more from July 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.